Messies et al. (24) demonstrated that CRP ≥ 180 mg/L on the 4th day after surgery was an independent risk factor for predicting anastomotic fistula after primary anastomosis in patients with rectal cancer (P = 0.002), with sensitivity and specificity of 72.3 and 88.9%, respectively. This evidence concerns the gene CRP and rectal cancer.